Ditchcarbon
  • Contact
  1. Organizations
  2. ArcherDx, Inc.
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated a month ago

ArcherDx, Inc. Sustainability Profile

Company website

ArcherDx, Inc., a leading player in the precision medicine industry, is headquartered in the United States, with significant operations across North America and Europe. Founded in 2013, the company has rapidly established itself as a pioneer in genomic profiling and next-generation sequencing technologies, focusing on oncology and rare diseases. ArcherDx is renowned for its innovative products, including the Archer FusionPlex and Archer VariantPlex assays, which enable comprehensive genomic analysis with unparalleled accuracy and sensitivity. These offerings are distinguished by their ability to detect a wide range of genetic alterations, making them invaluable tools for personalised cancer treatment. With a strong market position, ArcherDx has achieved notable milestones, including strategic partnerships and collaborations that enhance its research capabilities and expand its global reach. The company continues to drive advancements in molecular diagnostics, solidifying its reputation as a trusted leader in the field.

DitchCarbon Score

How does ArcherDx, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

ArcherDx, Inc.'s score of 23 is lower than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.

30%

Let us know if this data was useful to you

ArcherDx, Inc.'s reported carbon emissions

ArcherDx, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that ArcherDx may not have established formal commitments to reduce its carbon footprint or engage in industry-standard climate initiatives at this time. As the company operates within a sector increasingly focused on sustainability, it may benefit from developing and communicating clear climate commitments to align with industry best practices.

How Carbon Intensive is ArcherDx, Inc.'s Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. ArcherDx, Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is ArcherDx, Inc.'s Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for ArcherDx, Inc. is in US, which has a low grid carbon intensity relative to other regions.

ArcherDx, Inc.'s Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

ArcherDx, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare ArcherDx, Inc.'s Emissions with Industry Peers

Revvity

US
•
Health and social work services (85)
Updated 14 days ago

Thermo Fisher Scientific

US
•
Medical, precision and optical instruments, watches and clocks (33)
Updated 3 days ago

BostonGene Corporation

US
•
Research and development services (73)
Updated 1 day ago

Freenome Holdings, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 14 days ago

Fulgent Genetics

US
•
Other business services (74)
Updated 14 days ago

Genomic Health, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated about 2 months ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251114.2
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
AWS Marketplace logo
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy